What We’re Reading: Biden Eyes Cohen for CDC; Bias in PFTs; US Birthrate Stays Flat
June 2nd 2023President Joe Biden has reportedly picked former North Carolina health chief Mandy Cohen, MD, MPH, as next head of the CDC; Black men were probably underdiagnosed with lung problems because of software bias; the US birthrate remains flat.
Read More
Sick restaurants workers are among the main drivers of foodborne illness outbreaks at restaurants, according to the CDC; Sackler family members of Purdue Pharma can be protected from opioid liability, an appeals court rules; Sweden nears becoming the first “smoke free” country in Europe as daily cigarette use falls.
Read More
Dr Rana McKay on Second-line Treatment Options for Advanced RCC
May 30th 2023In the second part of a 2-part series, Rana R. McKay, MD, associate professor of Medicine and Urology, Moores Cancer Center, University of California San Diego, discusses second-line treatment options for advanced renal cell carcinoma (RCC).
Read More
What We’re Reading: MA BCBS Partners With Tufts; Medicaid Drug Price Audit; SC Passes Abortion Ban
May 24th 2023Blue Cross Blue Shield in Massachusetts sets agreement with Tufts Medicine using equity benchmarks; drug prices covered by Medicaid to undergo yearly audit; South Carolina abortion ban headed to governor as Planned Parenthood announces national staff cutbacks to shift resources to the states.
Read More
Dr Rana McKay on First-line Therapies for Metastatic Renal Cell Carcinoma
May 23rd 2023In this first part of a 2-part series, Rana R. McKay, MD, associate professor of Medicine and Urology, Moores Cancer Center, University of California San Diego, provides an overview of the treatment landscape for advanced renal cell carcinoma.
Read More
What We’re Reading: Expanding Student Health Care; Depression Soars; RSV Vaccine for Infants
May 18th 2023The Biden administration said it will expand health care access, including mental health care, to students; depression reaches an all-time high in the United States; the FDA’s independent vaccine advisers are meeting to discuss the safety and effectiveness of a respiratory syncytial virus (RSV) vaccine.
Read More
Black populations suffered 1.6 million excess deaths in the past 20 years, new studies find; the Federal Trade Commission (FTC) sues to block Amgen from acquiring Horizon Therapeutics, citing 2 drugs that have no competition; cancer drug shortages are approaching an all-time high.
Read More
Dr Jason Porter: Focus on Patient-Centered Care in the Treatment of Small Cell Lung Cancer
May 15th 2023It is important to have a multidisciplinary approach in the treatment of patients with small cell lung cancer, according to Jason Porter, MD, medical oncologist and hematologist, West Cancer Center and Research Institute, Memphis, Tennessee. This team approach allows for early intervention with signs of relapse or progression.
Read More
The end of the national Public Health Emergency (PHE) also concludes some public support programs; FDA advisers unanimously recommended that the agency should approve OTC birth control pills; insulin manufacturers and pharmacy benefit managers testified on Capitol Hill Wednesday over the cost of the drug.
Read More
Florida Cancer Specialists Highlights Role in Development of Polatuzumab Vedotin Plus R-CHP in DLBCL
May 10th 2023Florida Cancer Specialists recently released a case study that outlined its role in the evolution of a first-line therapy for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) that recently received FDA approval.
Read More
Biotech company EQRx discards low-cost drug plan, cuts its therapy programs to 1, and slashes staff in “reset”; health care systems’ preparation for new Alzheimer disease drug takes location and resources into consideration; the Drug Enforcement Administration (DEA) will extend telemedicine prescribing for certain controlled medications through at least November 11.
Read More
The end of the COVID-19 public health emergency spotlights US outbreak tracking weakness; the American Psychological Association released guidelines to guide teen social media use; the first study funded by the US government to measure safe injection site effectiveness was announced Monday.
Read More
Dr Linda D. Bradley: How Payers Can Improve Care for Endometriosis
May 8th 2023It's not normal to be in so much pain that you miss work several times a month and there are more things payers can do, said Linda D. Bradley, MD, professor of Obstetrics and Gynecology and Reproductive Medicine, Cleveland Clinic.
Read More